Publications of Erdmann Rapp

Zuniga-Banuelos, F. J.; Hoffmann, M.; Reichl, U.; Rapp, E.: New Avenues for Human Blood Plasma Biomarker Discovery via Improved In-Depth Analysis of the Low-Abundant N-glycoproteome. Engineering (2025)

Arigoni-Affolter, I.; Losfeld, M.-E.; Hennig, R.; Rapp, E.; Aebi, M.: A hierarchical structure in the N-glycosylation process governs the N-glycosylation output: prolonged cultivation induces glycoenzymes expression variations that are reflected in the cellular N-glycome but not in the protein and site-specific glycoprofile of CHO cells. Glycobiology 34 (8), cwae045 (2024)

Böttinger, K.; Regl, C.; Schäpertöns, V.; Rapp, E.; Wohlschlager, T.; Huber, C. G.: “Small is beautiful” – examining reliable determination of low- abundant therapeutic antibody glycovariants. Journal of Pharmaceutical Analysis 14 (10), 100982 (2024)

Karsten, C. B.; Buettner, F. F. R.; Cajic, S.; Nehlmeier, I.; Roshani, B.; Klippert, A.; Sauermann, U.; Stolte-Leeb, N.; Reichl, U.; Gerardy-Schahn, R. et al.; Rapp, E.; Stahl-Hennig, C.; Pöhlmann, S.: Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. PLOS Pathogens 20 (5), e1012190 (2024)

Burock, R.; Cajic, S.; Hennig, R.; Buettner, F. F. R.; Reichl, U.; Rapp, E.: Reliable N-Glycan Analysis–Removal of Frequently Occurring Oligosaccharide Impurities by Enzymatic Degradation. Molecules 28 (4), 1843 (2023)

Cajic, S.; Hennig, R.; Grote, V.; Reichl, U.; Rapp, E.: Removable Dyes—The Missing Link for In-Depth N-glycan Analysis via Multi-Method Approaches. Engineering 26, pp. 132 - 150 (2023)

Hussnaetter, K. P.; Palm, P.; Pich, A.; Franzreb, M.; Rapp, E.; Elling, L.: Strategies for Automated Enzymatic Glycan Synthesis (AEGS). Biotechnology Advances 67, 108208 (2023)

Morticelli, L.; Rossdam, C.; Cajic, S.; Böthig, D.; Magdei, M.; Tuladhar, S. R.; Petersen, B.; Fischer, K.; Rapp, E.; Korossis, S. et al.; Haverich, A.; Schnieke, A.; Niemann, H.; Buettner, F. F. R.; Hilfiker, A.: Genetic knockout of porcineGGTA1orCMAH/GGTA1is associated with the emergence of neo‐glycans. Xenotransplantation 30 (4), e12804 (2023)

Trbojević-Akmačić, I.; Vučković, F.; Pribić, T.; Vilaj, M.; Černigoj, U.; Vidič, J.; Šimunović, J.; Kępka, A.; Kolčić, I.; Klarić, L. et al.; Novokmet, M.; Pučić-Baković, M.; Rapp, E.; Štrancar, A.; Polašek, O.; Wilson, J. F.; Lauc, G.: Comparative analysis of transferrin and IgG N-glycosylation in two human populations. Communications Biology 6, 312 (2023)

Wenzel, L.; Hoffmann, M.; Rapp, E.; Rexer, T.; Reichl, U.: Cell-free N-glycosylation of peptides using synthetic lipid-linked hybrid and complex N-glycans. Frontiers in Molecular Biosciences 10, 1266431 (2023)

Beimdiek, J.; Hennig, R.; Burock, R.; Puk, O.; Biskup, S.; Rapp, E.; Lesinski-Schiedat, A.; Buettner, F. F. R.; Das, A. M.: Serum N-glycomics of a novel CDG-IIb patient reveals aberrant IgG glycosylation. Glycobiology 32 (5), pp. 380 - 390 (2022)

Hinterholzer, A.; Moises, J.; Regl, C.; Schwap, S.; Rapp, E.; Huber, C. G.; Schubert, M.: Unambiguous identification of α-Gal epitopes in intact monoclonal antibodies by NMR spectroscopy. mAbs 14 (1), 2132977 (2022)

Hütte, H. J.; Tiemann, B.; Shcherbakova, A.; Grote, V.; Hoffmann, M.; Povolo, L.; Lommel, M.; Strahl, S.; Vakhrushev, S. Y.; Rapp, E. et al.; Buettner, F. F. R.; Halim, A.; Imberty, A.; Bakker, H.: A Bacterial Mannose Binding Lectin as a Tool for the Enrichment of C- and O-Mannosylated Peptides. Analytical Chemistry 94 (20), pp. 7329 - 7338 (2022)

Lageveen-Kammeijer, G. S. M.; Rapp, E.; Chang, D.; Rudd, P. M.; Kettner, C.; Zaia, J.: The minimum information required for a glycomics experiment (MIRAGE): reporting guidelines for capillary electrophoresis. Glycobiology 32 (7), pp. 580 - 587 (2022)

Tolonen, A. C.; Beauchemin, N.; Bayne, C.; Li, L.; Tan, J.; Lee, J.; Meehan, B. M.; Meisner, J.; Millet, Y.; LeBlanc, G. et al.; Kottler, R.; Rapp, E.; Murphy, C.; Turnbaugh, P. J.; von Maltzahn, G.; Liu, C. M.; van Hylckama Vlieg, J. E. T.: Synthetic glycans control gut microbiome structure and mitigate colitis in mice. Nature Communications 13 (1), 1244 (2022)

Chuzel, L.; Fossa, S. L.; Boisvert, M. L.; Cajic, S.; Hennig, R.; Ganatra, M. B.; Reichl, U.; Rapp, E.; Taron, C. H.: Combining functional metagenomics and glycoanalytics to identify enzymes that facilitate structural characterization of sulfated N-glycans. Microbial Cell Factories 20 (20), 162 (2021)

Di Marco, F.; Berger, T.; Esser-Skala, W.; Rapp, E.; Regl, C.; Huber, C. G.: Simultaneous Monitoring of Monoclonal Antibody Variants by Strong Cation-Exchange Chromatography Hyphenated to Mass Spectrometry to Assess Quality Attributes of Rituximab-Based Biotherapeutics. International Journal of Molecular Sciences 22 (16), 9072 (2021)

Eussen, S. R. B. M.; Mank, M.; Kottler, R.; Hoffmann, X.-K.; Behne, A.; Rapp, E.; Stahl, B.; Mearin, M. L.; Koletzko, B.: Presence and Levels of Galactosyllactoses and Other Oligosaccharides in Human Milk and Their Variation during Lactation and According to Maternal Phenotype. Nutrients 13 (7), 2324 (2021)

Feichtinger, R. G.; Hüllen, A.; Koller, A.; Kotzot, D.; Grote, V.; Rapp, E.; Hofbauer, P.; Brugger, K.; Thiel, C.; Mayr, J. A. et al.; Wortmann, S. B.: A spoonful of L‐fucose—an efficient therapy for GFUS‐CDG, a new glycosylation disorder. Embo Molecular Medicine 13 (9), e14332 (2021)

Gücüm, S.; Sakson, R.; Hoffmann, M.; Grote, V.; Becker, C.; Pakari, K.; Beedgen, L.; Thiel, C.; Rapp, E.; Ruppert, T. et al.; Thumberger, T.; Wittbrodt, J.: A patient-based medaka alg2 mutant as a model for hypo-N-glycosylation. Development 148 (11), dev199385 (2021)